AHMEDABAD, India, June 21, 2010 - Zydus Cadila, a global healthcare provider and one of India's
leading healthcare companies has received Phase I clinical trial permission
from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at
the Zydus Research Centre using a unique platform technology, ZYOG1 is a
novel, oral, anti-diabetic molecule.
Volantis Systems Increases Global Presence with new Central Asia Office in Pune, India
WATERLOO, Canada, June 20, 2010 - In a public address before a packed audience at Perimeter Institute for
Theoretical Physics (PI), Prof. Stephen Hawking, PI Distinguished Research
Chair, recounted his research, life and times, saying that it has been a
glorious period to contribute to our picture of the universe. Prof. Hawking
is conducting private research activities at PI this summer, in what is
expected to be the first of many visits.
Global Ranking Shows More Transparency, More Programs for Low-income Countries
Independent Ranking Shows More Transparency, More Programs for Low-income Countries
More News
- Indian Drug Makers Ranked in New 'Access to Medicine Index'
- Generic Drug Makers Ranked in New 'Access to Medicine Index'
- Camp Ashraf Families of Mojahedin Cult Offered Solidarity by Paris Conference
- Ireland Funds Reports US$7M Grants for First Half 2010 at Largest Ever Summit of Diaspora Network Leaders in Dublin
